Chemomab Therapeutics Ltd.
CMMB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,011 | -$24,159 | -$27,538 | -$12,487 |
| Dep. & Amort. | $53 | $67 | $58 | $34 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$2,121 | -$946 | $3,991 | -$1,950 |
| Other Non-Cash | $620 | $1,487 | $3,198 | $2,020 |
| Operating Cash Flow | -$15,459 | -$23,550 | -$20,290 | -$12,383 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$3 | -$68 | -$239 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$45,983 |
| Inv. Sales/Matur. | $2,308 | $15,841 | $19,524 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $1,005 |
| Investing Cash Flow | $2,308 | $15,838 | $19,457 | -$45,217 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9,915 | $3,495 | $408 | $58,688 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$1,213 | $2,429 |
| Financing Cash Flow | $9,915 | $3,495 | -$805 | $61,116 |
| Forex Effect | $15 | -$11 | -$45,927 | $52,253 |
| Net Chg. in Cash | -$3,221 | -$4,228 | -$47,566 | $55,770 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,368 | $13,596 | $61,162 | $5,392 |
| End Cash | $6,147 | $9,368 | $13,596 | $61,162 |
| Free Cash Flow | -$15,459 | -$23,553 | -$20,358 | -$12,622 |